Recombinant Human CCNB3 Protein，GST

CCNB3, or Cyclin B3, is a member of the cyclin family involved in cell cycle regulation, particularly in the transition from the G2 phase to mitosis. It has garnered significant attention in cancer research due to its potential role in tumorigenesis and cell proliferation. Studies have shown that CCNB3 is overexpressed in various tumors, suggesting it may serve as a biomarker for cancer diagnosis or prognosis, as well as a potential therapeutic target. The protein's distinct expression patterns during meiosis and mitosis further imply its involvement in germ cell development and reproductive biology. Additionally, research has indicated that CCNB3 interacts with various cyclin-dependent kinases (CDKs), influencing the phosphorylation of critical substrates necessary for cell division. Given its pivotal role in cell cycle control and its association with cancer, the recombinant expression and characterization of CCNB3 becomes crucial. Investigating its structure and function through recombinant protein technology enables a better understanding of its mechanisms and interactions, paving the way for novel cancer therapies and interventions targeting cyclin-dependent pathways. As such, CCNB3 is a promising candidate for further exploration in both fundamental research and clinical applications, highlighting the need for continued studies into its biochemical properties and potential as a drug target.